The emergence of new viral infections of humans requires the development of robust diagnostic tests, which can be applied in the differential diagnosis of acute illness or to determine past exposure to establish the true burden of disease. In the time since the recognition of the SARS coronavirus as the causative agent of the syndrome of SARS in April 2003, enormous efforts have been applied internationally to develop molecular and serological tests for SARS which can assist rapid detection of cases, accurate diagnosis of illness, and assist the application of control measures. This chapter describes the work involved in developing such tests.
|Title of host publication||SARS|
|Subtitle of host publication||A Case Study in Emerging Infections|
|Publisher||Oxford University Press|
|Publication status||Published - 1 Sep 2007|
Bibliographical notePublisher Copyright:
© Oxford University Press, 2013. All Rights Reserved.
- Control measures
- Diagnostic tests
- Molecular tests
- Serological tests